General Information
Revision date
2024-08-01
Product name
Opticlox Eye Ointment
Product name
Opticlox Eye Ointment
Identification on the label/Trade name
Opticlox Eye Ointment 50938
CAS No.
23736-58-5
1.2.1 Relevant identified uses
For the treatment of bovine keratoconjunctivitis where cloxacillin susceptible bacteria (including Moraxella bovis) are suspected or anticipated as pathogens. Also for the treatment of bacterial keratoconjunctivitis caused by cloxacillin-susceptible bac...
Icons in SDS
Company Information
company name
Norbrook Laboratories Australia Pty Ltd
GHS Information
Signal word
NONE. Not hazardous
Section 2
SECTION 2: Hazards identification
SUSMP Classification
S4
ADG classification
None allocated. Not a Dangerous Good under the ADG Code
UN Number
None allocated
Signal word
NONE. Not hazardous
Prevention
P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required.
Response
P337 If eye irritation persists seek medical attention P353: Rinse skin or shower with water. P301+P330+P331 IF SWALLOWED Rinse mouth. Do NOT induce vomiting P370+P378: In case of fire, use carbon dioxide, dry chemical, foam, water fog.
Storage
P410: Protect from sunlight. P402+P404: Store in a dry place. Store in a closed container. P403+P235: Store in a well-ventilated place. Keep cool.
Disposal
P501: If product can not be recycled, consider controlled incineration, or contact a specialist waste disposal company (see Section 13 of this SDS). Emergency Overview Physical Description & Colour: Smooth sterile cream coloured, cream. Odour: Odourless.
Health hazards
no significant risk factors have been found for this product. This is an antibiotic preparation Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results.
